These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 28615068)

  • 1. Quantitative proteomics in lung cancer.
    Cheung CHY; Juan HF
    J Biomed Sci; 2017 Jun; 24(1):37. PubMed ID: 28615068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of proteomics in non-small-cell lung cancer.
    Cho WC
    Expert Rev Proteomics; 2016; 13(1):1-4. PubMed ID: 26577456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of lung cancer genomics and proteomics.
    Granville CA; Dennis PA
    Am J Respir Cell Mol Biol; 2005 Mar; 32(3):169-76. PubMed ID: 15713815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery.
    Indovina P; Marcelli E; Pentimalli F; Tanganelli P; Tarro G; Giordano A
    Mass Spectrom Rev; 2013; 32(2):129-42. PubMed ID: 22829143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics biomarkers for non-small cell lung cancer.
    Kisluk J; Ciborowski M; Niemira M; Kretowski A; Niklinski J
    J Pharm Biomed Anal; 2014 Dec; 101():40-9. PubMed ID: 25175018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current proteomic analysis and post-translational modifications of biomarkers in human lung cancer materials.
    Sinchaikul S; Hongsachart P; Sriyam S; Tantipaiboonwong P; Phutrakul S; Chen ST
    Chang Gung Med J; 2008; 31(5):417-30. PubMed ID: 19097588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of potential protein biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid by SWATH MS data-independent acquisition and targeted data extraction.
    Ortea I; Rodríguez-Ariza A; Chicano-Gálvez E; Arenas Vacas MS; Jurado Gámez B
    J Proteomics; 2016 Apr; 138():106-14. PubMed ID: 26917472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of reverse phase protein array (RPPA)-based pathway-activation profiling in 84 non-small cell lung cancer (NSCLC) cell lines as platform for cancer proteomics and biomarker discovery.
    Ummanni R; Mannsperger HA; Sonntag J; Oswald M; Sharma AK; König R; Korf U
    Biochim Biophys Acta; 2014 May; 1844(5):950-9. PubMed ID: 24361481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shotgun and Targeted Plasma Proteomics to Predict Prognosis of Non-Small Cell Lung Cancer.
    Li QR; Liu YS; Zeng R
    Methods Mol Biol; 2017; 1619():385-394. PubMed ID: 28674898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent mass spectrometry-based proteomics for biomarker discovery in lung cancer, COPD, and asthma.
    Fujii K; Nakamura H; Nishimura T
    Expert Rev Proteomics; 2017 Apr; 14(4):373-386. PubMed ID: 28271730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A; Ma PC; Salgia R
    Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic biomarkers in lung cancer.
    Pastor MD; Nogal A; Molina-Pinelo S; Carnero A; Paz-Ares L
    Clin Transl Oncol; 2013 Sep; 15(9):671-82. PubMed ID: 23606351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative proteomics for identification of cancer biomarkers.
    Chaerkady R; Pandey A
    Proteomics Clin Appl; 2007 Sep; 1(9):1080-9. PubMed ID: 21136759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research Progress of Biomakers Proteomics-based in Lung Cancer].
    Xie H; Chen Z; Wang G
    Zhongguo Fei Ai Za Zhi; 2015 Jun; 18(6):391-6. PubMed ID: 26104898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical proteomics for cancer biomarker discovery and therapeutic targeting.
    Krieg RC; Paweletz CP; Liotta LA; Petricoin EF
    Technol Cancer Res Treat; 2002 Aug; 1(4):263-72. PubMed ID: 12625785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular insights into cancer drug resistance from a proteomics perspective.
    An Y; Zhou L; Huang Z; Nice EC; Zhang H; Huang C
    Expert Rev Proteomics; 2019 May; 16(5):413-429. PubMed ID: 30925852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of Proteomics in Lung Research.
    Reisdorph NA; Michel C; Fritz K; Reisdorph R
    Methods Mol Biol; 2018; 1809():237-262. PubMed ID: 29987793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of the low molecular weight serum proteome using 18O stable isotope labeling in a lung tumor xenograft mouse model.
    Hood BL; Lucas DA; Kim G; Chan KC; Blonder J; Issaq HJ; Veenstra TD; Conrads TP; Pollet I; Karsan A
    J Am Soc Mass Spectrom; 2005 Aug; 16(8):1221-30. PubMed ID: 15979327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
    Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
    J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of oncoproteomics to cancer biomarker discovery.
    Cho WC
    Mol Cancer; 2007 Apr; 6():25. PubMed ID: 17407558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.